Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Vasopressin antagonism in heart failure.

Goldsmith SR, Gheorghiade M.

J Am Coll Cardiol. 2005 Nov 15;46(10):1785-91. Epub 2005 Oct 21. Review.

PMID:
16286160
[PubMed - indexed for MEDLINE]
Free Article
2.

Vasopressin receptor antagonists: mechanisms of action and potential effects in heart failure.

Goldsmith SR.

Cleve Clin J Med. 2006 Jun;73 Suppl 2:S20-3; discussion S30-3. Review.

PMID:
16786909
[PubMed - indexed for MEDLINE]
Free Article
3.

Is there a cardiovascular rationale for the use of combined vasopressin V1a/V2 receptor antagonists?

Goldsmith SR.

Am J Med. 2006 Jul;119(7 Suppl 1):S93-6. Review.

PMID:
16843092
[PubMed - indexed for MEDLINE]
4.

Hyponatremia in heart failure: the role of arginine vasopressin and its antagonism.

Rosner MH, Ronco C.

Congest Heart Fail. 2010 Jul;16 Suppl 1:S7-14. doi: 10.1111/j.1751-7133.2010.00156.x. Review.

PMID:
20653716
[PubMed - indexed for MEDLINE]
5.

Hyponatremia in heart failure: the role of arginine vasopressin and diuretics.

Rosner MH.

Cardiovasc Drugs Ther. 2009 Aug;23(4):307-15. doi: 10.1007/s10557-009-6180-9. Review.

PMID:
19554441
[PubMed - indexed for MEDLINE]
6.

The role of arginine vasopressin and its receptors in the normal and failing rat heart.

Chandrashekhar Y, Prahash AJ, Sen S, Gupta S, Roy S, Anand IS.

J Mol Cell Cardiol. 2003 May;35(5):495-504.

PMID:
12738231
[PubMed - indexed for MEDLINE]
7.

Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.

LeJemtel TH, Serrano C.

Int J Cardiol. 2007 Aug 9;120(1):1-9. Epub 2007 Mar 8. Review.

PMID:
17346825
[PubMed - indexed for MEDLINE]
8.

Overview of vasopressin receptor antagonists in heart failure resulting in hospitalization.

De Luca L, Orlandi C, Udelson JE, Fedele F, Gheorghiade M.

Am J Cardiol. 2005 Dec 19;96(12A):24L-33L. Epub 2005 Nov 8. Review.

PMID:
16399090
[PubMed - indexed for MEDLINE]
9.

Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials.

Miyazaki T, Fujiki H, Yamamura Y, Nakamura S, Mori T.

Cardiovasc Drug Rev. 2007 Spring;25(1):1-13. Review.

PMID:
17445084
[PubMed - indexed for MEDLINE]
10.

Treating hyponatremia in heart failure.

Goldsmith SR.

Curr Cardiol Rep. 2006 May;8(3):204-10. Review.

PMID:
17552085
[PubMed - indexed for MEDLINE]
11.

Congestive heart failure: potential role of arginine vasopressin antagonists in the therapy of heart failure.

Goldsmith SR.

Congest Heart Fail. 2002 Sep-Oct;8(5):251-6. Review.

PMID:
12368587
[PubMed - indexed for MEDLINE]
12.

The role of vasopressin in congestive heart failure.

Goldsmith SR.

Cleve Clin J Med. 2006 Sep;73 Suppl 3:S19-23. Review.

PMID:
16970149
[PubMed - indexed for MEDLINE]
Free Article
13.

Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.

Schrier RW.

Am J Med. 2006 Jul;119(7 Suppl 1):S47-53. Review.

PMID:
16843085
[PubMed - indexed for MEDLINE]
14.

Hyponatremia and vasopressin antagonism in congestive heart failure.

Kumar S, Rubin S, Mather PJ, Whellan DJ.

Clin Cardiol. 2007 Nov;30(11):546-51. Review.

PMID:
17847041
[PubMed - indexed for MEDLINE]
15.

Nonpeptide vasopressin antagonists: a new group of hormone blockers entering the scene.

Mayinger B, Hensen J.

Exp Clin Endocrinol Diabetes. 1999;107(3):157-65. Review.

PMID:
10376439
[PubMed - indexed for MEDLINE]
16.

Conivaptan: a selective vasopressin antagonist.

Sulemanjee NZ, Schwarz ER.

Drugs Today (Barc). 2006 Jun;42(6):379-86. Review.

PMID:
16845441
[PubMed - indexed for MEDLINE]
17.

Neurohormonal activation in congestive heart failure and the role of vasopressin.

Chatterjee K.

Am J Cardiol. 2005 May 2;95(9A):8B-13B. Review.

PMID:
15847852
[PubMed - indexed for MEDLINE]
18.

Effects of nonpeptide vasopressin V2 antagonist tolvaptan in rats with heart failure.

Veeraveedu PT, Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K, Suzuki K, Kodama M, Aizawa Y.

Biochem Pharmacol. 2007 Nov 15;74(10):1466-75. Epub 2007 Jul 22.

PMID:
17720144
[PubMed - indexed for MEDLINE]
19.

Novel therapies for heart failure: vasopressin and selective aldosterone antagonists.

Kamath SA, Laskar SR, Yancy CW.

Congest Heart Fail. 2005 Jan-Feb;11(1):21-9. Review.

PMID:
15722667
[PubMed - indexed for MEDLINE]
20.

The clinical effects of vasopressin receptor antagonists in heart failure.

Gheorghiade M.

Cleve Clin J Med. 2006 Jun;73 Suppl 2:S24-9; discussion S30-3.

PMID:
16786910
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk